@docakx: In 2016, virologist Beata Halassy was diagnosed with invasive triple-negative breast cancer (multiple foci). Treatment …
Summary
Virologist Beata Halassy self-treated her recurrent breast cancer with lab-prepared viruses, achieving remission and redirecting her research to oncolytic virotherapy.
View Cached Full Text
Cached at: 08/15/26, 09:47 AM
In 2016, virologist Beata Halassy was diagnosed with invasive triple-negative breast cancer (multiple foci). Treatment involved mastectomy of the left breast plus adjuvant chemotherapy.
In 2020, she found that her breast cancer had come back for the second time in the same place. The tumour had grown into nearby tissue and was considered advanced. She did not want more chemotherapy.
Unwilling to undergo further chemotherapy, she prepared research-grade measles vaccine strain and vesicular stomatitis virus in her laboratory. A colleague injected these viruses directly into the tumour over two months under oncologist supervision.
The tumour shrank a lot and became easier to remove. Doctors then took it out with surgery, and she took trastuzumab ( cancer drug) for one year. She has stayed cancer-free for more than four and a half years.
This was a careful one-person experiment not a standard treatment for others. Her successful self-treatment completely changed the direction of her laboratory. She is now focused on oncolytic virotherapy (using viruses to fight cancer) research.
Similar Articles
@EricTopol: The ramp up of cancer immunotherapy is remarkable. Now we're seeing vaccines achieve some cures or remissions in the mo…
Eric Topol highlights the remarkable progress in cancer immunotherapy, with vaccines achieving cures or remissions in refractory cancers like pancreatic, melanoma, glioblastoma, renal, and triple-negative breast cancer, and directs readers to his Ground Truths newsletter for more.
ChatGPT and Cancer: How a Tech Founder Rewrote His Treatment Plan
GitLab co-founder Sid Sijbrandij open-sourced 25 TB of multi-omic tumor data and used ChatGPT-driven agents to design custom therapies, including a FAP-targeted radioligand and an mRNA vaccine, for his relapsed osteosarcoma.
@YannickBuccella: The newer generation cancer vaccines aren't like the HPV shot (that prevents a virus). These are therapeutic, they trea…
The article discusses the advancement of therapeutic cancer vaccines using personalized mRNA technology, highlighting recent positive Phase 3 results for melanoma and ongoing trials for other cancers, with potential approvals expected by 2027.
@EricTopol: Big progress vs cancer, folks. The kind of event curves from randomized trials that we've not seen before for a couple …
Big progress against two of the most deadly cancers reported from randomized trials, as highlighted by Eric Topol during the ASCO conference.
Colon cancer’s invisibility cloak removed by eliminating a single gene - a fundamental breakthrough. The result was 100% eradication of tumours when paired with immunotherapy treatment in mouse models.
New University of Calgary research shows that knocking out a single gene makes colon cancer cells visible to the immune system, and when combined with immunotherapy, leads to 100% tumor eradication in mouse models, offering a potential new approach for treating colorectal cancer.